Pharmaceutical sponsors and contract research organization’s perception toward genetic data reuse for future research

Author:

Devarinti Revanasiddappa1,Ganachari M. S.1

Affiliation:

1. Department of Pharmacy Practice, KLE College of Pharmacy, Belagavi, Karnataka, India

Abstract

Abstract Background: Pharmaceutical sponsors and Contract research organization plays vital role in the preparation and implementation of clinical trials and give rise to ethical predicaments that pertain to various aspects such as general or genetic consent, optional research, storage and utilization of genetic data and specimens, as well as disclosure of research findings to study participants. Objective: The current investigation is to assess the knowledge, attitudes, and practices of Clinical Research Organizations and Pharmaceutical Sponsors in relation to re-use of genetic research data for future research. Study Participants and Methodology: A cross-sectional study conducted on pharmaceutical sponsor and their representatives from the metro cities, India. Results: The present research encompassed N=50 of pharmaceutical sponsors and contract research organizations. Among these, 84% evinced cognizance regarding the re-use of genetic data in clinical trials. Furthermore, 62% of pharmaceutical sponsors and contract research organizations articulated apprehensions with respect to ethical and legal quandaries might arise due to the re-use of genomic data. Discussion: A considerable proportion of participants are a willingness to share and reuse genetic data for future studies. However, it is observed that the perception towards practice is low, particularly in relation to the return of genetic results and ethical concerns while storing genetic samples. Conclusion: There are presently no universally accepted international Conference on Harmonization of Technical Requirements for Pharmaceuticals for Human Use (ICH) guidelines in place for the management of genetic sampling and data at the global level. In India, however, ICMR regulations exist to provide direction for the use of biological materials and datasets in research.

Publisher

Medknow

Subject

General Medicine

Reference6 articles.

1. Global public perceptions of genomic data sharing: What shapes the willingness to donate DNA and health data;Middleton;Am J Hum Genet,2020

2. Public perspectives regarding data-sharing practices in genomics research;Haga;Public Health Genomics,2011

3. Genomic research and wide data sharing: Views of prospective participants;Trinidad;Genet Med,2010

4. How Geisinger made the case for an institutional duty to return genomic results to biobank participants;Faucett;Appl Transl Genom.,2016

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3